Philibert, Aline
Da Silva, Judy
Fillion, Myriam
Mergler, Donna
Funding for this research was provided by:
Canadian Institutes of Health Research (152882, 152882, 152882, 152882)
Article History
Received: 9 February 2024
Accepted: 6 May 2024
First Online: 31 May 2024
Declarations
:
: The GN-CHA (2016–2017) and the Niibin study (2021–2022) were conducted in accordance with the Declaration of Helsinki as well as the OCAP® Principles of Ownership, Control, Access, and Possession. Ethics approval for the GN-CHA was obtained from the Manitoulin Anishinaabek Research Review Committee (MARRC), who issued an Ethics Certificate on November 11, 2016. Ethics approval for the study linking GN-CHA data to Hg exposure data was obtained from the Université du Québec à Montréal Research Ethics Board (2016_e_1350) and Health Canada Research Ethics Board (REB 2017–0006). Ethics approval for the Niibin study (2021–2022) was obtained from the Université du Québec à Montréal Research Ethics Board (#3763_e_2020) and MARRC (#2022–06).For the GN-CHA and Niibin study, informed consent forms were signed by all participants. Consent included survey participation and the linking of the information from both studies to data obtained from previous surveillance programs or studies of Hg exposure.
: All authors have read and approved the manuscript, which was reviewed and approved for publication by Grassy Narrows Chief and Council.
: The authors declare no competing interests.